• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Conatus Pharmaceuticals Inc. (CNAT)

    -NasdaqGM
    5.85 Down 0.11(1.85%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:5.96
    Open:6.04
    Bid:N/A
    Ask:6.06 x 1000
    1y Target Est:13.00
    Beta:-0.520
    Next Earnings Date:N/A
    Day's Range:5.80 - 6.17
    52wk Range:5.06 - 13.18
    Volume:242,229
    Avg Vol (3m):676,587
    Market Cap:90.83M
    P/E (ttm):N/A
    EPS (ttm):-1.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CNATDown 1.85%90.83M
    GALTDown 6.67%71.24M
    ICPTUp 17.77%4.29B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.59
    Quarterly EPS Est (Dec-14) :-0.49
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-3.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback